Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

A venous thromboembolism (VTE) with the subsequent risk of pulmonary embolism is a major concern in the treatment of patients with multiple myeloma with thalidomide. The susceptibility to developing a VTE in response to thalidomide therapy is likely to be influenced by both genetic and environmental...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Johnson, David C., Corthals, Sophie, Ramos, Christine, Hoering, Antje, Cocks, Kim, Dickens, Nicholas J., Haessler, Jeff, Goldschmidt, Harmut, Child, J. Anthony, Bell, Sue E., Jackson, Graham, Baris, Dalsu, Rajkumar, S. Vincent, Davies, Faith E., Durie, Brian G. M., Crowley, John, Sonneveld, Pieter, Van Ness, Brian, Morgan, Gareth J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2008
Gaiak:
Hemostasis, Thrombosis, and Vascular Biology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3601865/
https://ncbi.nlm.nih.gov/pubmed/18805967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140434
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak